Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual companion 'Ida' may ease cancer distress in kids

NCT ID NCT07742059

Symptom relief Sponsor: Koç University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether an augmented reality (AR) app-based cognitive behavioral therapy (CBT) program can help children aged 6 to 12 who are undergoing chemotherapy for cancer cope with treatment-related distress and improve their quality of life. Participants are randomly assigned to one of three groups: one using the AR app 'My Hospital Buddy Ida,' another receiving the same CBT content through a printed workbook, and a control group receiving usual hospital care. The study compares changes in quality of life, resilience, anxiety, and treatment-related symptoms like nausea and fatigue across the groups over about 9 to 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Augmented reality-supported cognitive behavioral therapy (CBT) delivered via a smartphone/tablet app with an interactive companion character, compared to standard CBT via a printed workbook and usual care.
What this could lead to
If effective, this could offer a new, engaging way to help children with cancer manage treatment-related distress and improve their quality of life.
What could go wrong
The trial is relatively small and early, and the benefits of the AR app over standard CBT or usual care are not yet proven. The app may not be suitable for all children, and its effects could be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

114 people

The number who actually took part.

Started

Apr 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of any childhood cancer * Currently within the first 4 months of chemotherapy treatment * Has completed at least 1 prior chemotherapy cycle * Sufficient Turkish language ability to complete study measures * Presence of a literate caregiver able to provide consent and assist with study procedures Exclusion Criteria: * Chronic illness other than cancer * Diagnosed brain disease * Epilepsy * Severe neurodevelopmental or neurological disorder * Clouded consciousness or delirium * History of motion sickness * Sensory or cognitive impairment precluding use of the AR application

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Cancer-related distress Pediatric cancer Quality of life

Contacts and locations

Locations

  • Akdeniz Üniversitesi Hastanesi

    Antalya, Turkey (Türkiye)

  • Koç University Hospital

    Istanbul, Turkey (Türkiye)

  • Marmara Üniversitesi Pendik Eğitim ve Araştırma Hastanesi

    Istanbul, Turkey (Türkiye)

  • İstanbul Üniversitesi Onkoloji Enstitüsü

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.